1、newsreleaseHumanaInc.500WestMainStreetP.O.Box1438Louisville,KY40202http:/FORMOREINFORMATIONCONTACT:LisaStonerHumanaInvestorRelations(502)580-2652e-mail:LSMarkTaylorHumanaCorporateCommunications(317)753-0345e-mail:MTHumanaReportsSecondQuarter2024FinancialResults;AffirmsFullYearAdjusted2024FinancialGu

2、idanceReports2Q24earningspershare(EPS)of$5.62onaGAAPbasis,AdjustedEPSof$6.96;reportsYTD2024EPSof$11.74onaGAAPbasis,$14.19onanAdjustedbasisRevises FY 2024 EPS guidance to approximately$12.81(previously approximately$13.93)on a GAAP basis,whileaffirmingAdjustedEPSofapproximately$16.00;affirmsFY2024Ins

3、urancesegmentbenefitratioofapproximately90percentRaises2024individualMedicareAdvantageannualmembershipgrowthby75,000tonowanticipateannualgrowthofapproximately225,000,or4.2percentPublishesLetterfromtheCEOandpreparedmanagementremarkstoInvestorRaheadofthismornings9:00a.m.ETquestionandanswersessiontodis

4、cussitsfinancialresultsforthequarterandexpectationsforfutureearningsLOUISVILLE,KY(July31,2024)HumanaInc.(NYSE:HUM)todayreportedconsolidatedpretaxresultsanddilutedearningspershare(EPS)forthequarterendedJune30,2024(2Q24)versusthequarterendedJune30,2023(2Q23)andforthesixmonthsendedJune30,2024(YTD2024)v

5、ersusthesixmonthsendedJune30,2023(YTD2023)asnotedinthetablesbelow.1Consolidatedincomebeforeincometaxesandequityinnetearnings(pretaxresults)Inmillions2Q24(a)2Q23(a)YTD2024(a)YTD2023(a)GenerallyAcceptedAccountingPrinciples(GAAP)$918$1,262$1,932$2,876Amortizationassociatedwithidentifiableintangibles15

6、16 31 34Put/callvaluationadjustmentsassociatedwiththecompanysnon-consolidatingminorityinterestinvestments68 53 199 107Impactofexitofemployergroupcommercialmedicalproductsbusiness59 45 60(37)Valuecreationinitiatives68 97 Transactionandintegrationcosts 4(48)Accruedchargerelatedtocertainanticipatedliti